Last reviewed · How we verify

Sculptra Aesthetic — Competitive Intelligence Brief

Sculptra Aesthetic (Sculptra Aesthetic) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biostimulatory dermal filler. Area: Dermatology / Aesthetics.

marketed Biostimulatory dermal filler Fibroblast collagen synthesis (non-receptor mediated) Dermatology / Aesthetics Small molecule Live · refreshed every 30 min

Target snapshot

Sculptra Aesthetic (Sculptra Aesthetic) — Erevna Innovations Inc.. Sculptra Aesthetic stimulates collagen production in the skin through a biostimulatory effect, gradually restoring facial volume and improving skin texture.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sculptra Aesthetic TARGET Sculptra Aesthetic Erevna Innovations Inc. marketed Biostimulatory dermal filler Fibroblast collagen synthesis (non-receptor mediated)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biostimulatory dermal filler class)

  1. Erevna Innovations Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sculptra Aesthetic — Competitive Intelligence Brief. https://druglandscape.com/ci/sculptra-aesthetic. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: